Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
Amgen Inc (NASDAQ: AMGN) Delayed: 347.01 +2.29 (0.66%)
Previous Close $344.72    52 Week High $176.85 
Open $348.31    52 Week Low $133.64 
Day High $349.40    P/E 52.26 
Day Low $345.49    EPS $6.64 
Volume 2,304,948